Seagen Stock

Seagen ROCE 2024

Seagen ROCE

-0.22

Ticker

SGEN

ISIN

US81181C1045

WKN

602322

In 2024, Seagen's return on capital employed (ROCE) was -0.22, a -1.76% increase from the -0.22 ROCE in the previous year.

Seagen Aktienanalyse

What does Seagen do?

Seagen Inc is a pharmaceutical and biotech company specialized in the development of drugs for cancer treatment and supporting the health of patients with chronic diseases. The company was founded in 1997 and has its headquarters in Bothell, Washington. Seagen Inc's history began when the founders, Clay Siegall and H. Perry Fell, decided to establish a company focused on developing innovative technologies and biological solutions for fighting cancer. The company started with a small workforce and a focus on the development of antibodies against cancer cells. Over the years, Seagen has become a major player in the industry and has launched several successful drugs worldwide. Seagen Inc specializes in the development of cancer medications, including antibodies against cancer cells. The company strives to improve the effectiveness of cancer treatments and reduce the number of side effects. Its flagship products are Adcetris and Padcev, both used for the treatment of specific types of cancer. Adcetris (Brentuximab Vedotin) is an antibody-drug conjugate and the first of its kind approved worldwide for use against Hodgkin lymphomas and systemic anaplastic large cell lymphoma. It contains a special chemical that is bound to an antibody to directly attack cancer cells. Adcetris has proven to be very effective against lymphomas and is available on prescription in many countries. Padcev (Enfortumab Vedotin-ejfv) is another antibody-drug conjugate used for the treatment of bladder cancer. The drug has shown effectiveness in clinical studies and has been approved by the FDA to help patients who have no other treatment options. Padcev is being developed and marketed by Seagen in collaboration with Astellas Pharma. In addition to developing cancer medications, Seagen Inc is also involved in the research and development of technologies for autoimmune disease therapy. The company has developed a technology platform that has proven to be highly effective in the development of antibody-based therapies. This platform is used both internally and in partnerships with other pharmaceutical companies. Seagen Inc also leverages partnerships to expand its business globally and advance the development of new therapies. The company has entered into a strategic partnership with Takeda Pharmaceutical to support the development and commercialization of Adcetris. Additionally, Seagen Inc collaborates with various universities and research institutions to develop new technologies and treatment options. Overall, Seagen Inc has experienced strong growth in recent years and has become a major player in the biotech and pharmaceutical industry. The company remains committed to its mission of developing innovative technologies and solutions for fighting cancer and other chronic diseases. Seagen ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Seagen's Return on Capital Employed (ROCE)

Seagen's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Seagen's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Seagen's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Seagen’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Seagen stock

What is the ROCE (Return on Capital Employed) of Seagen this year?

The ROCE of Seagen is -0.22 undefined this year.

How has the ROCE (Return on Capital Employed) of Seagen developed compared to the previous year?

The ROCE of Seagen has increased by -1.76% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Seagen?

A high Return on Capital Employed (ROCE) indicates that Seagen has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Seagen?

A low ROCE (Return on Capital Employed) can indicate that Seagen has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Seagen impact the company?

An increase in the ROCE of Seagen can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Seagen affect the company?

A decrease in ROCE of Seagen can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Seagen?

Some factors that can affect Seagen's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Seagen so important for investors?

The ROCE of Seagen is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Seagen take to improve the ROCE?

To improve the ROCE, Seagen can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Seagen pay?

Over the past 12 months, Seagen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Seagen is expected to pay a dividend of 0 USD.

What is the dividend yield of Seagen?

The current dividend yield of Seagen is .

When does Seagen pay dividends?

Seagen pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Seagen?

Seagen paid dividends every year for the past 0 years.

What is the dividend of Seagen?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Seagen located?

Seagen is assigned to the 'Health' sector.

Wann musste ich die Aktien von Seagen kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Seagen from 9/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Seagen pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Seagen in the year 2023?

In the year 2023, Seagen distributed 0 USD as dividends.

In which currency does Seagen pay out the dividend?

The dividends of Seagen are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Seagen

Our stock analysis for Seagen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Seagen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.